[Federal Register Volume 79, Number 89 (Thursday, May 8, 2014)]
[Notices]
[Pages 26441-26442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-10608]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Cancer Institute Clinical Trials and Translational Research 
Advisory Committee.
    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.

[[Page 26442]]

    Date: June 18, 2014.
    Time: 4 p.m. to 5 p.m.
    Agenda: Review of the CTAC Small Cell Lung Cancer (SCLC) Working 
Group's Report.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, 6 West--CCCT Huddle, Rockville, MD 20892 
(Virtual Meeting).
    Go To: https://cbiit.webex.com/cbiit/j.php?MTID=mb9db8379b9faf5ef42f384b469c5ebdb.
    Meeting Password--Tim@l1ne.
    Meeting Number--730 501 868.

AUDIO CONNECTION
    1. Provide your number when you join the meeting to receive a 
call back. Alternatively, you can call one of the following numbers: 
Dial In Number: 1-240-276-6338.
    2. Follow the instructions that you hear on the phone. Your 
Cisco Unified Meeting Place meeting ID: 730 501 868.

    Contact Person: Sheila A. Prindiville, MD, MPH, Director, 
Coordinating Center for Clinical Trials, National Institutes of 
Health, National Cancer Institute, Coordinating Center for Clinical 
Trials, 9609 Medical Center Drive Room 6W136, Rockville, MD 20850, 
240-276-6173, [email protected].

    Name of Committee: Clinical Trials Strategic Planning 
Subcommittee, National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.
    Date: July 8, 2014.
    Time: 2 p.m. to 3 p.m.
    Agenda: Review the final report of the NCI National Clinical 
Trials Network Working Group.
    Place: National Cancer Institute Shady Grove, 6West CCCT Huddle 
Room, 9609 Medical Center Drive, Rockville, MD 20850 
(Teleconference), 1-866-652-9542, Password: 4596704.
    Contact Person: Sheila A. Prindiville, MD, MPH, Director, 
Coordinating Center for Clinical Trials, National Institutes of 
Health, National Cancer Institute, 9609 Medical Center Drive Room 
6W136 Rockville, MD 20850, 240-276-6173, [email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where 
agendas and any additional information for the meetings will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 5, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-10608 Filed 5-7-14; 8:45 am]
BILLING CODE 4140-01-P